NO970732L - Ultrasoniske kontrastmidler, fremgangsmåte ved fremstilling derav samt deres anvendelse som diagnostiske midler - Google Patents

Ultrasoniske kontrastmidler, fremgangsmåte ved fremstilling derav samt deres anvendelse som diagnostiske midler

Info

Publication number
NO970732L
NO970732L NO970732A NO970732A NO970732L NO 970732 L NO970732 L NO 970732L NO 970732 A NO970732 A NO 970732A NO 970732 A NO970732 A NO 970732A NO 970732 L NO970732 L NO 970732L
Authority
NO
Norway
Prior art keywords
agents
preparation
ultrasonic contrast
diagnostic
diagnostic agents
Prior art date
Application number
NO970732A
Other languages
English (en)
Other versions
NO304412B1 (no
NO970732D0 (no
Inventor
Michael Stein
Dieter Heldmann
Thomas Fritzsch
Joachim Siegert
Georg Roessling
Ulrich Speck
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25864722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO970732(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE3803972A external-priority patent/DE3803972A1/de
Priority claimed from DE3803971A external-priority patent/DE3803971C2/de
Publication of NO970732L publication Critical patent/NO970732L/no
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO970732D0 publication Critical patent/NO970732D0/no
Publication of NO304412B1 publication Critical patent/NO304412B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/228—Host-guest complexes, clathrates, chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Steroid Compounds (AREA)
NO970732A 1988-02-05 1997-02-17 Ultrasonisk kontrastmiddel samt anvendelse derav ved fremstilling av et preparat for ultralyddiagnostikk NO304412B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3803972A DE3803972A1 (de) 1988-02-05 1988-02-05 Ultraschallkontrastmittel
DE3803971A DE3803971C2 (de) 1988-02-05 1988-02-05 Ultraschallkontrastmittel
PCT/DE1989/000069 WO1989006978A1 (en) 1988-02-05 1989-02-01 Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents

Publications (3)

Publication Number Publication Date
NO970732L true NO970732L (no) 1990-10-03
NO970732D0 NO970732D0 (no) 1997-02-17
NO304412B1 NO304412B1 (no) 1998-12-14

Family

ID=25864722

Family Applications (2)

Application Number Title Priority Date Filing Date
NO903443A NO301260B1 (no) 1988-02-05 1990-08-06 Ultrasoniske kontrastmidler samt anvendelse av slike ved fremstilling av et preparat for ultralyddiagnostikk
NO970732A NO304412B1 (no) 1988-02-05 1997-02-17 Ultrasonisk kontrastmiddel samt anvendelse derav ved fremstilling av et preparat for ultralyddiagnostikk

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO903443A NO301260B1 (no) 1988-02-05 1990-08-06 Ultrasoniske kontrastmidler samt anvendelse av slike ved fremstilling av et preparat for ultralyddiagnostikk

Country Status (20)

Country Link
US (3) US6264959B1 (no)
EP (3) EP0586875A1 (no)
JP (2) JP2907911B2 (no)
KR (1) KR0133132B1 (no)
CN (1) CN1033840C (no)
AT (1) ATE109663T1 (no)
AU (1) AU635200B2 (no)
CA (1) CA1336164C (no)
DE (1) DE58908194D1 (no)
DK (1) DK175832B1 (no)
ES (1) ES2068917T3 (no)
FI (1) FI99086C (no)
HU (1) HU221485B (no)
IE (2) IE66912B1 (no)
IL (1) IL89175A (no)
MY (1) MY105856A (no)
NO (2) NO301260B1 (no)
NZ (1) NZ227869A (no)
PT (1) PT89635B (no)
WO (1) WO1989006978A1 (no)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5425366A (en) * 1988-02-05 1995-06-20 Schering Aktiengesellschaft Ultrasonic contrast agents for color Doppler imaging
DE4219724A1 (de) * 1992-06-13 1993-12-16 Schering Ag Verwendung von Mikrokapseln als Kontrastmittel für die Farbdoppler-Sonographie
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
DE4004430A1 (de) * 1990-02-09 1991-08-14 Schering Ag Aus polyaldehyden aufgebaute kontrastmittel
GB2256183B (en) * 1990-02-20 1994-03-09 Delta Biotechnology Ltd Double emulsion technique producing diagnostic aid microcapsules for pharmaceutical use
GB9003821D0 (en) * 1990-02-20 1990-04-18 Danbiosyst Uk Diagnostic aid
US5445813A (en) 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IN172208B (no) 1990-04-02 1993-05-01 Sint Sa
US5578292A (en) * 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
USRE39146E1 (en) * 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US5190982A (en) * 1990-04-26 1993-03-02 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5205287A (en) * 1990-04-26 1993-04-27 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5137928A (en) * 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5370901A (en) 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
DE69215722T3 (de) * 1991-03-22 2001-03-08 Katsuro Tachibana Verstärker zur Ultraschalltherapie von Erkrankungen sowie diesen enthaltende flüssige Arzneimittelzusammensetzungen
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
EP0514790A2 (de) * 1991-05-24 1992-11-25 Hoechst Aktiengesellschaft Polykondensate, die Weinsäurederivate enthalten, Verfahren zu ihrer Herstellung und Verwendung derselben
DK0586524T3 (no) * 1991-06-03 1997-05-20 Nycomed Imaging As
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
NZ244147A (en) * 1991-09-03 1994-09-27 Hoechst Ag Echogenic particles which comprise a gas and at least one shaping substance, and their use as diagnostic agents
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
MX9205298A (es) 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
CZ286149B6 (cs) * 1991-09-17 2000-01-12 Sonus Pharmaceuticals, Inc. Plynná prostředí pro zvýšení kontrastnosti obrazu, získaného ultrazvukem a způsob výběru plynů pro toto použití
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
GB9204918D0 (en) 1992-03-06 1992-04-22 Nycomed As Chemical compounds
DE4219723A1 (de) * 1992-06-13 1993-12-16 Schering Ag Mikropartikel, Verfahren zu deren Herstellung, sowie die Verwendung dieser in der Diagnostik
DE4232755A1 (de) * 1992-09-26 1994-03-31 Schering Ag Mikropartikelpräparationen aus biologisch abbaubaren Mischpolymeren
US6383470B1 (en) 1992-09-26 2002-05-07 Thomas Fritzsch Microparticle preparations made of biodegradable copolymers
GB9221329D0 (en) 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
NZ262237A (en) * 1993-01-25 1997-06-24 Sonus Pharma Inc Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in
GB9305349D0 (en) * 1993-03-16 1993-05-05 Nycomed Imaging As Improvements in or relating to contrast agents
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
PT711179E (pt) * 1993-07-30 2005-03-31 Imcor Pharmaceutical Company Composicoes de microbolhas estabilizadas para ultra-som
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
HUT74509A (en) * 1993-09-09 1997-01-28 Schering Ag Active principles and gas containing microparticles, their use for realising active principles in ultrasonically controlled manner, and process for preparing them
ES2192572T3 (es) 1993-12-15 2003-10-16 Bracco Research Sa Medios de contraste de ultrasonidos, agentes de contraste que contienen los medios, y metodo.
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
WO1995029705A1 (en) * 1994-05-03 1995-11-09 Molecular Biosystems, Inc. Composition for ultrasonically quantitating myocardial perfusion
US5965109A (en) * 1994-08-02 1999-10-12 Molecular Biosystems, Inc. Process for making insoluble gas-filled microspheres containing a liquid hydrophobic barrier
US5562893A (en) * 1994-08-02 1996-10-08 Molecular Biosystems, Inc. Gas-filled microspheres with fluorine-containing shells
US5730955A (en) * 1994-08-02 1998-03-24 Molecular Biosystems, Inc. Process for making gas-filled microspheres containing a liquid hydrophobic barrier
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
DE19508049C2 (de) * 1995-02-23 1997-02-06 Schering Ag Verwendung von Methylenmalondiesterderivaten zur Herstellung von gasenthaltenden Mikropartikeln
DE19510690A1 (de) * 1995-03-14 1996-09-19 Schering Ag Polymere Nano- und/oder Mikropartikel, Verfahren zu deren Herstellung, sowie Verwendung in medizinischen Diagnostik und Therapie
US5759539A (en) * 1995-06-06 1998-06-02 Georgia Research Foundation, Inc. Method for rapid enzymatic alcohol removal
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US5820850A (en) * 1995-06-07 1998-10-13 Molecular Biosystems, Inc. Gas-filled amino acid block co-polymer microspheres useful as ultrasound contrast agents
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE19543077C2 (de) * 1995-11-13 1997-10-16 Schering Ag Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel
CZ281298A3 (cs) * 1996-03-05 1999-01-13 Acusphere, Inc. Fluorované plyny v mikrokapslích jako zobrazující činidla pro ultrazvukové vyšetření
US5611344A (en) * 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
WO1997040679A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US6017310A (en) * 1996-09-07 2000-01-25 Andaris Limited Use of hollow microcapsules
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
ES2189974T3 (es) 1996-09-11 2003-07-16 Imarx Pharmaceutical Corp Procedimientos mejorados para la obtencion de imagenes de diagnostico usando un agente de contraste y un vasodilatador.
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
GB9701274D0 (en) 1997-01-22 1997-03-12 Andaris Ltd Ultrasound contrast imaging
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6193951B1 (en) * 1997-04-30 2001-02-27 Point Biomedical Corporation Microparticles useful as ultrasonic contrast agents
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
GB9800813D0 (en) 1998-01-16 1998-03-11 Andaris Ltd Improved ultrasound contrast imaging method and apparatus
DE19813174A1 (de) * 1998-03-25 1999-05-27 Schering Ag Mikropartikel aus Polymeren und mindestens einer gerüstbildenden Komponente und ihre Herstellung und Verwendung in der Ultraschalldiagnostik und zur ultraschallinduzierten Wirkstofffreisetzung
DE19839216C1 (de) * 1998-08-28 2000-01-20 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von sphärischen Mikropartikeln, die ganz oder teilweise aus mindestens einem wasserunlöslichen Verzweigungen enthaltenden Polyglucan bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und die Verwendung
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US6862470B2 (en) * 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US20090216118A1 (en) * 2007-07-26 2009-08-27 Senorx, Inc. Polysaccharide markers
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
DE19925311B4 (de) * 1999-05-27 2004-06-09 Schering Ag Mehrstufen-Verfahren zur Herstellung von gasgefüllten Mikrokapseln
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
EP1202671A4 (en) 1999-08-13 2004-11-10 Point Biomedical Corp MICROPARTICLES USEFUL AS ULTRASONIC CONTRAST AGENTS FOR THE LYMPHATIC SYSTEM
WO2001012069A1 (en) 1999-08-13 2001-02-22 Point Biomedical Corporation Hollow microspheres with controlled fragility for medical use
AU2002239290A1 (en) 2000-11-20 2002-06-03 Senorx, Inc. Tissue site markers for in vivo imaging
US8512680B2 (en) 2001-08-08 2013-08-20 Btg International Ltd. Injectables in foam, new pharmaceutical applications
ATE319378T1 (de) 2001-12-03 2006-03-15 Ekos Corp Katheter mit mehreren ultraschall-abstrahlenden teilen
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
CA2506422A1 (en) * 2002-11-22 2004-06-10 Basf Aktiengesellschaft Enzymatic synthesis of polyol acrylates
US20040185108A1 (en) * 2003-03-18 2004-09-23 Short Robert E. Method of preparing gas-filled polymer matrix microparticles useful for delivering drug
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
WO2005041897A2 (en) 2003-10-31 2005-05-12 Point Biomedical Corporation Reconstitutable microsphere compositions useful as ultrasonic contrast agents
US8048439B2 (en) 2003-11-17 2011-11-01 Btg International Ltd. Therapeutic foam
JP2007511590A (ja) 2003-11-17 2007-05-10 ビーティージー・インターナショナル・リミテッド 治療用フォーム
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US7025726B2 (en) 2004-01-22 2006-04-11 The Regents Of The University Of Nebraska Detection of endothelial dysfunction by ultrasonic imaging
ITMI20041056A1 (it) * 2004-05-26 2004-08-26 Garrido Antonio Luis Cabrera Uso in campo medico diagnostico e flebo logico di una kiscela di gas sterili e fisiologicamente accettabili
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
EA011516B1 (ru) 2005-01-13 2009-04-28 Синвеншен Аг Композиционный материал и способ его изготовления
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
GB0509824D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Therapeutic foam
US20100168554A1 (en) * 2005-06-30 2010-07-01 Jens Sorensen Evaluating Cardiac Function With Dynamic Imaging Techniques and Contrast Media
CN100484479C (zh) * 2005-08-26 2009-05-06 深圳迈瑞生物医疗电子股份有限公司 超声图像增强与斑点抑制方法
US7967763B2 (en) 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
CA2562580C (en) 2005-10-07 2014-04-29 Inrad, Inc. Drug-eluting tissue marker
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US20080230001A1 (en) * 2006-02-23 2008-09-25 Meadwestvaco Corporation Method for treating a substrate
EP2015846A2 (en) 2006-04-24 2009-01-21 Ekos Corporation Ultrasound therapy system
WO2008051749A2 (en) 2006-10-23 2008-05-02 C. R. Bard, Inc. Breast marker
EP2109409B1 (en) 2006-12-12 2018-09-05 C.R.Bard, Inc. Multiple imaging mode tissue marker
ES2432572T3 (es) 2006-12-18 2013-12-04 C.R. Bard, Inc. Marcador de biopsia con propiedades de obtención de imágenes generadas in situ
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
EP2170181B1 (en) 2007-06-22 2014-04-16 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
WO2009099767A2 (en) 2008-01-31 2009-08-13 C.R. Bard, Inc. Biopsy tissue marker
EP2285901B1 (en) 2008-05-06 2020-07-22 CJ CheilJedang Corporation Biodegradable polyester blends
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US8670818B2 (en) 2008-12-30 2014-03-11 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
US9475930B2 (en) 2012-08-17 2016-10-25 Metabolix, Inc. Biobased rubber modifiers for polymer blends
JP2014195581A (ja) * 2013-03-29 2014-10-16 オリンパス株式会社 超音波治療装置
EP3004225A1 (en) 2013-05-30 2016-04-13 Metabolix, Inc. Recyclate blends
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
CN106459544B (zh) 2014-03-27 2021-10-01 Cj 第一制糖株式会社 高度填充的聚合物体系
WO2016201136A1 (en) 2015-06-10 2016-12-15 Ekos Corporation Ultrasound catheter

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429827A (en) 1962-11-23 1969-02-25 Moore Business Forms Inc Method of encapsulation
US4572869A (en) 1967-04-20 1986-02-25 Ppg Industries, Inc. Microcapsular opacifiers and method for their production
US4173488A (en) 1968-12-23 1979-11-06 Champion International Corporation Oil-in-water emulsions containing hydropholeic starch
US4069306A (en) 1974-03-14 1978-01-17 Pharmacia Aktiebolag X-ray contrast preparation containing a hydrophilic polymer containing amino groups
US4142526A (en) * 1974-12-23 1979-03-06 Alza Corporation Osmotic releasing system with means for changing release therefrom
US4089800A (en) 1975-04-04 1978-05-16 Ppg Industries, Inc. Method of preparing microcapsules
US4177177A (en) 1976-03-26 1979-12-04 El Aasser Mohamed S Polymer emulsification process
US4186131A (en) * 1977-04-21 1980-01-29 Mead Johnson & Company Phenyltetrazolyloxy propanolamines
US4370160A (en) * 1978-06-27 1983-01-25 Dow Corning Corporation Process for preparing silicone microparticles
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4265251A (en) 1979-06-28 1981-05-05 Rasor Associates, Inc. Method of determining pressure within liquid containing vessel
ATE17311T1 (de) 1980-11-17 1986-01-15 Schering Ag Praeparat zur erzeugung von mikroblaeschen.
US4681119A (en) 1980-11-17 1987-07-21 Schering Aktiengesellschaft Method of production and use of microbubble precursors
US4657756A (en) 1980-11-17 1987-04-14 Schering Aktiengesellschaft Microbubble precursors and apparatus for their production and use
US4442843A (en) 1980-11-17 1984-04-17 Schering, Ag Microbubble precursors and methods for their production and use
US4365251A (en) 1980-12-04 1982-12-21 Westinghouse Electric Corp. Electrically driven meter totalizing device
HU180183B (en) * 1980-12-19 1983-02-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing stable suppository compositions containing volatile and/or labile active substances
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
HU183430B (en) * 1981-05-12 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
IL63220A (en) 1981-07-01 1985-09-29 Yeda Res & Dev Process for production of polyacrolein microspheres
DE3141641A1 (de) * 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
US4637905A (en) 1982-03-04 1987-01-20 Batelle Development Corporation Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
DE3313946A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
US5141738A (en) 1983-04-15 1992-08-25 Schering Aktiengesellschaft Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof
DE3313947A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
US4900540A (en) 1983-06-20 1990-02-13 Trustees Of The University Of Massachusetts Lipisomes containing gas for ultrasound detection
DE3341001A1 (de) * 1983-11-12 1985-05-23 Krause, Hans Jürgen Nanopartikel aus bioabbaubarem, synthetischem material, verfahren zu deren herstellung und ihre anwendung
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
US5618514A (en) 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
SU1357410A1 (ru) * 1985-01-24 1987-12-07 Предприятие П/Я Р-6710 Способ получени соединений включени @ -циклодекстрина и инертных газов
US4886068A (en) 1985-07-29 1989-12-12 Kabushiki Kaisha Toshiba Ultrasonic coupling agent
DE3529195A1 (de) * 1985-08-14 1987-02-26 Max Planck Gesellschaft Kontrastmittel fuer ultraschalluntersuchungen und verfahren zu seiner herstellung
CS255758B1 (en) * 1985-12-11 1988-03-15 Frantisek Rypacek Preparat for the diagnostic of transportion function of oviduct and process for preparing thereof
DE3785365T2 (de) * 1986-01-08 1993-09-16 Kao Corp Badezusatz.
US4741872A (en) 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
FR2604903B1 (fr) 1986-10-08 1989-01-13 Sopar Sa Nv Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
DE3637926C1 (de) 1986-11-05 1987-11-26 Schering Ag Ultraschall-Manometrieverfahren in einer Fluessigkeit mittels Mikroblaeschen
US5174930A (en) * 1986-12-31 1992-12-29 Centre National De La Recherche Scientifique (Cnrs) Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions
FR2608942B1 (fr) 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
US4844882A (en) * 1987-12-29 1989-07-04 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent
US5425366A (en) 1988-02-05 1995-06-20 Schering Aktiengesellschaft Ultrasonic contrast agents for color Doppler imaging
DE8900069U1 (de) * 1989-01-04 1989-03-09 Schneider, Elke, 4052 Korschenbroich Kaminbausatz
US5205287A (en) * 1990-04-26 1993-04-27 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5236693A (en) 1990-11-14 1993-08-17 Brigham And Women's Hospital Medical ultrasound contrast agent and method of using same
US5107842A (en) 1991-02-22 1992-04-28 Molecular Biosystems, Inc. Method of ultrasound imaging of the gastrointestinal tract
US5147631A (en) 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
JPH05262673A (ja) 1992-03-19 1993-10-12 Nippon Paint Co Ltd 超音波診断用造影剤

Also Published As

Publication number Publication date
MY105856A (en) 1995-02-28
ES2068917T3 (es) 1995-05-01
NO304412B1 (no) 1998-12-14
IE66912B1 (en) 1996-02-07
WO1989006978A1 (en) 1989-08-10
HU221485B (en) 2002-10-28
KR900700137A (ko) 1990-08-11
IL89175A0 (en) 1989-09-10
CN1035437A (zh) 1989-09-13
EP0398935A1 (de) 1990-11-28
JPH03503634A (ja) 1991-08-15
DK186490D0 (da) 1990-08-03
FI99086C (fi) 1997-10-10
NO301260B1 (no) 1997-10-06
DE58908194D1 (de) 1994-09-22
US6177062B1 (en) 2001-01-23
DK186490A (da) 1990-08-23
AU635200B2 (en) 1993-03-18
IL89175A (en) 1993-02-21
JP2907911B2 (ja) 1999-06-21
JP3027326B2 (ja) 2000-04-04
PT89635B (pt) 1994-02-28
NO903443L (no) 1990-10-03
AU3035189A (en) 1989-08-25
DK175832B1 (da) 2005-03-14
ATE109663T1 (de) 1994-08-15
KR0133132B1 (ko) 1998-04-17
NO903443D0 (no) 1990-08-06
JPH08208524A (ja) 1996-08-13
US6264959B1 (en) 2001-07-24
IE890343L (en) 1989-08-05
FI903865A0 (fi) 1990-08-03
EP0398935B1 (de) 1994-08-10
PT89635A (pt) 1989-10-04
EP0327490A1 (de) 1989-08-09
EP0586875A1 (de) 1994-03-16
IE940809L (en) 1989-08-05
US6071496A (en) 2000-06-06
NO970732D0 (no) 1997-02-17
NZ227869A (en) 1992-11-25
CA1336164C (en) 1995-07-04
CN1033840C (zh) 1997-01-22
HUT59322A (en) 1992-05-28
HU891055D0 (en) 1991-01-28
FI99086B (fi) 1997-06-30

Similar Documents

Publication Publication Date Title
NO970732L (no) Ultrasoniske kontrastmidler, fremgangsmåte ved fremstilling derav samt deres anvendelse som diagnostiske midler
BR9005637A (pt) Sistema interativo para guiar o uso de uma ferramenta cirurgica,braco mecanico e metodo de execucao de um procedimento cirurgico
BR8805440A (pt) Processo para a fabricacao de 1,1,1-trifluorodicloroetano e/ou 1,1,1,2-tetrafluorocloroetano por fluoracao de um tetrahaloetileno
IT1222394B (it) Processo per la preparazione di 2,2,6,6 tetrametil 4 piperidilammine
PT94226A (pt) Processo de preparacao de 1,2-dioxetanos que produzem quimioluminescencia por activacao dupla
NO307646B1 (no) Mikropartikkel samt fremgangsmÕte for fremstilling av denne
FI895389A0 (fi) Foerfarande foer framstaellning av 3,5 -dimetyl-4-metoxipyridinderivat samt ny mellanprodukt haerfoer.
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE58906162D1 (de) Verfahren zur Herstellung eines gegebenenfalls substituierten Chinacridons.
DK354188D0 (da) Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
PT90176A (pt) Processo para a preparacao de um agente de tratamento de gado equideo
DE68918787D1 (de) Verfahren zur Herstellung von Cyclopentanderivaten.
BR8907500A (pt) Hidrofluoretacao catalisada de alcenos
BR8903860A (pt) Processo para preparacao de derivados liquidos ou capazes de fluencia de gorduras e oleos naturais,derivados liquidos ou capazes de fluencia obtidos e emprego
DE69008670D1 (de) Verfahren zur Herstellung von Diarylmethanen.
DE58906820D1 (de) Verfahren zur Herstellung von Aralkylhydroperoxiden.
DE69016857D1 (de) Verfahren zur Herstellung von NiNi-Diakyl- 1,8-Naphthalendiamin.
PT89996A (pt) Processo para a preparacao de 3-(2,3,4,5,6-pentafluorofenoxi)-8-azabiciclo{3.2.1}octanos
BR8906485A (pt) Processo para a fabricacao de conexoes,disposicao ou arranjo para a execucao de um processo,arranjo e dispositivo
NO900219D0 (no) Dihydroksybenzofenon-oksim, samt fremgangsmaate for fremstilling av slike oksimer.
IT8720230A0 (it) Processo per la preparazione di 1-alchil-3-carbossi-4-cinnoloni.
IT8620526A0 (it) Processo per la preparazione de 3,4-dimetossifenilacetone.
BR8600507A (pt) Processo de obtencao de espelhamento para refletor odontologico,ou para outros usos
IT1236840B (it) Procedimento per la preparazione di alchil - e cicloalchil - idroperossidi terziari.
BR8900512A (pt) Processo para a preparacao de um poliisocianato alifatico ou cicloalifatico

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2003